Skip to content
Study details
Enrolling now

Wellness Intervention for Smoking and HIV

University of Arizona
NCT IDNCT04725617ClinicalTrials.gov data as of Apr 2026
Target enrollment

200

Study length

about 3.9 years

Ages

18–75

Locations

2 sites in AZ

What this study is about

This trial is testing a personalized approach to reduce smoking versus another health intervention on smoking cessation, healthy sleep metrics, and cardiovascular risk biomarkers in adults with HIV who smoke. Participants will receive varenicline and counseling sessions while being monitored for side effects.

Simplified from trial records by PatientMatch.

What you may be asked to do

  • 1.Health Approach 2 to Reduce Smoking
  • 2.Participate in Health Approach 1 to Reduce Smoking
  • 3.Participate in Smoking Cessation Counseling
  • +1 more

Participation Burden

What's physically and logistically required of participants.

Logistics & Travel
In-person visits

Requires travel to a study site

Physical Intervention
Oral

How treatment is administered

Treatment Assignment
Randomized & Blinded

You may get a placebo/standard care, and you won't know which.

Extracted study details

Pulled from the trial record to show what is being tested and what the study is measuring.

Drug classes

varenicline

Drug routes

oral (Oral Tablet)

Endpoints

Primary: Change in sleep duration

Secondary: Change in blood pressure, Change in sleep quality

Body systems

Cardiology / Heart, Immune, Infectious